Other topics in this section

Hepatitis B: latest news

Hepatitis B resources

Hepatitis B features

Hepatitis B news from aidsmap

More news

Hepatitis B news selected from other sources

  • Booster Shots Needed for People with HIV?

    Previous research indicates people with HIV have a reduced immune response to most vaccines, but how does immune response hold up over time—and what are the implications for re-vaccinating with “booster shots”?

    26 January 2014 | BETA blog
  • China's Struggle With Hepatitis B Discrimination

    Job applicants and students are regularly turned down on the basis of the disease. Now, some are fighting back.

    04 December 2013 | The Atlantic
  • Men-only hepatitis B mutation explains higher cancer rates

    A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer. Although some women do progress to cirrhosis and liver cancer, the mutation is absent in HBV in women. The research is published ahead of print in the Journal of Clinical Microbiology.

    18 October 2013 | Eurekalert Inf Dis
  • Vaccination campaign doubles HBV mutations

    A universal infant vaccination campaign in China has led the hepatitis B virus to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.

    08 October 2013 | Eurekalert Medicine & Health
  • FDA Warns of Hepatitis B Reactivation Risk with Immune-suppressing Cancer Drugs

    The U.S. Food and Drug Administration (FDA) announced this week that it has approved labeling changes for 2 monoclonal antibody cancer drugs, ofatumumab (Arzerra) and rituximab (Rituxan), adding a stronger "black box" warning that they may cause hepatitis B virus (HBV) reactivation.

    30 September 2013 | HIVandhepatitis.com
  • Medivir and Daewoong pull plug on hepatitis B drug

    Sweden’s Medivir and South Korean partner Daewoong Pharmaceutical Co have decided to discontinue development of their investigational hepatitis B compound.

    06 September 2013 | PharmaTimes
  • Hepatitis B Vaccination Cuts Deaths From Liver Disease, Cancer: Study

    Taiwan study highlights need for vaccination for all, U.S. expert says.Taiwanese researchers report a 90 percent reduction in deaths from complications of hepatitis B since the country began its infant vaccination program in 1984.

    04 September 2013 | U.S. News & World Report
  • New Hepatitis B vaccine developed

    Israeli drug company SciVac has developed a third generation vaccine for Hepatitis B that it believes will halt the global growth of the disease.

    13 August 2013 | KWWL.com
  • $25m to stem rise in HIV in Australia

    The Rudd government outlines a $25 million strategy to tackle sexually transmitted diseases such as HIV, which is on the rise for the first time in five years.

    12 August 2013 | Sydney Morning Herald
  • Changes to VIREAD (tenofovir DF) labeling for Hepatitis B

    FDA recently approved changes to VIREAD (tenofovir DF) product labeling regarding the 96-week safety and efficacy data from Study GS-US-174-0121 in adult subjects with lamivudine-resistant chronic hepatitis B virus (HBV) infection.

    29 July 2013 | FDA
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.